Drug
Aqua07
Aqua07: highest development phase Phase 1, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| AQUA07 NCT07617337 | Phase 1 | ALK Positive Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Aqua07 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.